Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (8): 74-79    DOI: 10.13523/j.cb.20190810
    
Research Progress of Exosome as Tumor Marker
LIU Yan1,2,DAI Peng2,ZHU Yun-feng1,**()
1 College of Life Sciences and Bioengineering,Beijing Jiaotong University,Beijing 100044,China
2 Henan Province OriginBio Biotechnology Co., Ltd., Zhengzhou 450000, China
Download: HTML   PDF(977KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Exosomes are naturally occurring biological nanomembranous vesicles (40 to 100 nm) of endocytic origin that are released into the extracellular space from diverse cell types . They have pleiotropic functions such as antigen presentation,intercellular transfer of protein , RNA and lipids. The exosomes secreted by tumor cells play an important role in the physiological and pathological processes which are involved in the occurrence, development and migration of tumors. At present, given the important significance for early diagnosis, for efficacy evaluation and prognosis analysis, the identification for specific markers from tumor exosomes has become the focus of cancer researchers. The recent advances of exosome in basic research as well as its application in cancer diagnosis were reviewed.



Key wordsTumor      Exosome      Molecular marker     
Received: 02 January 2019      Published: 18 September 2019
ZTFLH:  Q28  
Corresponding Authors: Yun-feng ZHU     E-mail: zhuyf2004@163.com
Cite this article:

LIU Yan,DAI Peng,ZHU Yun-feng. Research Progress of Exosome as Tumor Marker. China Biotechnology, 2019, 39(8): 74-79.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20190810     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I8/74

[1]   Pan B T, Johnstone R M . Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell, 1983,33(3):967-978.
[2]   Zheng H, Zhan Y, Liu S , et al. The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications. J Exp Clin Cancer Res, 2018,37(1):226.
[3]   Hartwig S, De Filippo E, G?ddeke S , et al. Exosomal proteins constitute an essential part of the human adipose tissue secretome. Biochim Biophys Acta Proteins Proteom, 2018, DOI: 10.1016/j.bbapap.2018.11.009.
doi: 10.1016/j.bbapap.2018.11.009
[4]   Graner M W, Cumming R I, Bigner D D . The heat shock response and chaperones /heat shock proteins in brain tumors: surface expression, release, and possible immune consequences. J Neurosci, 2007,27(42):11214-11227.
[5]   Colombo M, Moita C, Van N G , et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci, 2013,126(24):5553-5565.
[6]   Li X, Li X, Lin J , et al. Exosomes derived from low-intensity pulsed ultrasound-treated dendritic cells suppress tumor necrosis factor-induced endothelial inflammation. J Ultrasound Med, 2018, doi: 10.1002/jum. 14898.
doi: 10.1002/jum. 14898
[7]   Zhou Y, Xia L, Lin J , et al. Exosomes in nasopharyngeal carcinoma. J Cancer, 2018,9(5):767-777.
[8]   Klinge C M . Non-coding rnas in breast cancer: intracellular and intercellular communication. Noncoding RNA, 2018,4(4):40.
[9]   Xu Z, Yan Y, Zeng S , et al. Circular RNAs: clinical relevance in cancer. Oncotarget, 2017,9(1):1444-1460.
[10]   Zhong S, Chen X, Wang D , et al. MicroRNA expression profiles of drug- resistance breast cancer cells and their exosomes. Oncotarget, 2016,7(15):19601-19609.
[11]   Tanaka Y, Kamohara H, Kinoshita K , et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer, 2013,119(6):1159-1167.
[12]   Hannafon B N, Ding W Q. Functional role of microRNAs in the progression of breast ductal carcinoma in situ. Am J Pathol, 2018, pii: S0002-9440(18) 30380-30388.
[13]   Bei J C, Byrne F L, takenaka K , et al. Analysis of the circular RNA transcriptome in endometrial cancer. Oncotarget, 2018,5(pp):5786-5796.
[14]   Chin A R, Fong M Y, Somlo G , et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res, 2016,26(2):217-228.
[15]   Zeng Z, Li Y, Pan Y , et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun, 2018,9(1):5395.
[16]   Fujita Y, Kosaka N, Araya J , et al. Extracellular vesicles in lung micro- environment and pathogenesis. Trends Mol Med, 2015,21(9):533-542.
[17]   Tabernero L, Woodman P . Dissecting the role of His domain protein tyrosine phosphatase/PTPN23 and ESCRTs in sorting activated epidermal growth factor receptor to the multivesicular body. Biochem Soc Trans, 2018,46(5):1037-1046.
[18]   Migliano S M, Teis D . ESCRT and membrane protein ubiquitination. Prog Mol Subcell Biol, 2018,57:107-135.
[19]   Stuffers S, Sem W C, Stenmark H , et al. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic, 2009,10(7):925-937.
[20]   Dreux M, Garaigorta U, Boyd B , et al. Short range exosomal transtransfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe, 2012,12(4):558-570.
doi: 10.1016/j.chom.2012.08.010
[21]   van Niel G, Charrin S, Simoes S , et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell, 2011,21(4):708-721.
[22]   Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M , et al. Exosomes -structure, biogenesis and biological role in non small-cell lung cancer. Scand J Immunol, 2015,81(1):2-10.
[23]   Ludwig A K, Giebel B . Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol, 2012(44):11-15.
[24]   Wang S, Cesca F, Loers G , et al. Synapsin I is an oligomannose carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via gliaderived exosomes. J Neuroscience, 2011,31(20):7275-7290.
[25]   Vlassov A V, Magdaleno S, Setterquist R , et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta, 2012,1820(7):940-948.
[26]   Clotilde T, Muriel B, Philippe V , et al. Proteomic analysis of dendritic cell- derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol, 2001,166(12):7309-7318.
[27]   Hao S, Bai O, Li F , et al. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology, 2006,10(1111):1365-2567.
[28]   Alvarez-Erviti L, Seow Y, Yin H , et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 2011,29(4):341-345.
[29]   Qi H, Liu C, Long L , et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano, 2016,10(3):3323.
[30]   Chen Z, Fillmore C M, Hammerman P S , et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer, 2014,14(8) : 535-546.
[31]   Ueda K, Ishikawa N, Tatsuguchi A , et al. Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Sci Rep, 2014,4:6232.
[32]   Vanni I, Alama A, Grossi F , et al. Exosomes:a new horizon in lung cancer. Drug Discov Today, 2017(17):30110-30115.
[33]   Melo S A, Luecke L B, Kahlert C , et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 2015,523(7559):177-182.
[34]   Que R, Ding G, Chen J , et al. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol, 2013,11(1):1-9.
doi: 10.1186/1477-7819-11-1
[35]   Tauro B J, Greening D W, Mathias R A , et al. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics, 2013,12(3):587-598.
doi: 10.1074/mcp.M112.021303
[36]   Ogata-Kawata H, Izumiya M, Kurioka , et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One, 2014,9(4):e92921.
[37]   Hu D, Zhan Y, Zhu K , et al. Plasma exosomal long non-coding RNAs serve as biomarkers for early detection of colorectal cancer. Cell Physiol Biochem, 2018,51(6):2704-2715.
[38]   Szajnik M, Derbis M, Lach M , et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecology & Obstetrics, 2013,S4:003.
[39]   Ying X, Wu Q, Wu X , et al. Epithelial ovarian cancersecreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget, 2016,7(28):43076-43087.
[40]   Li Z, Ma Y Y, Wang J , et al. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. Onco Target Ther, 2016,9:139-148.
[41]   Zijlstra C, Stoorvogel W . Prostasomes as a source of diagnostic biomarkersfor prostate cancer. J Clin Invest, 2016,126(4):1144-1151.
[42]   Beckham C J, Olsen J, Yin P N , et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. The Journal of Urology, 2014,192(2):583-592.
[43]   Long J D, Sullivan T B, Humphrey J , et al. A non-invasive miRNA based assay to detect bladder cancer in cell-free urine. Am J Transl Res, 2015,7(11):2500-2509.
[44]   Zheng R, Du M, Wang X , et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer, 2018,17(1):143.
[45]   Halvaei S, Daryani S, Eslami-S Z , et al. Exosomes in cancer liquid biopsy: a focus on breast cancer. Mol Ther Nucleic Acids, 2018,10:131-141.
[46]   Li Y, Zheng Q, Bao C , et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res, 2015,25(8):981-984.
[47]   Xu H, Gong Z, Shen Y , et al. Circular RNA expression in extracellularvesicles isolated from serum of patients with endometrial cancer. Epigenomics, 2018,10(2):187-197.
[48]   Wang H, Hou L, Li A , et al. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int, 2014,2014:864894.
[49]   Fujiwara T, Uotani K, Yoshida A , et al. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Oncotarget, 2017,8(20):33375-33392.
[50]   Zhang Y, Luo C L, He B C , et al. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol, 2010,36(1):133-140.
[1] ZHAO Meng-ze,LI Feng-zhi,WANG Peng-yin,LI Jian,XU Han-mei. Research Progress of Dual-target Blocking Therapy of PD-L1 and VEGF[J]. China Biotechnology, 2021, 41(9): 71-77.
[2] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[3] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[4] LV Hui-zhong,ZHAO Chen-chen,ZHU Lian,XU Na. Progress of Using Exosome for Drug Targeted Delivery in Tumor Therapy[J]. China Biotechnology, 2021, 41(5): 79-86.
[5] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[6] DENG Rui,ZENG Jia-li,LU Xue-mei. Screening and Structure-activity Relationship Analysis of Anti-tumor Derived Peptides Based on Musca domestica cecropin[J]. China Biotechnology, 2021, 41(11): 14-22.
[7] WU You,XIN Lin. New Drug Delivery System: Delivery of Exosomes as Drug Carriers[J]. China Biotechnology, 2020, 40(9): 28-35.
[8] QIU Jin-ge,LIU De-wu,SUN Bao-li,LI Yao-kun,GUO Yong-qing,DENG Ming,LIU Guang-bin. Research Progress on Animal Exosome Isolation Methods[J]. China Biotechnology, 2020, 40(9): 36-42.
[9] YANG Wei,SONG Fang-xiang,WANG Shuai,ZHANG Li,WANG Hong-xia,LI Yan. Preparation and Application of Janus Nanoparticles in Drug Delivery System[J]. China Biotechnology, 2020, 40(7): 70-81.
[10] LIN Shi-xin,LIU Dong-chen,LEI Yun,XIONG Sheng,XIE Qiu-ling. Screening, Expression and Specificity Detection of Anti-TNF-α Nanobody[J]. China Biotechnology, 2020, 40(7): 15-21.
[11] ZHANG Bao-hui,XIONG Hua-long,ZHANG Tian-ying,YUAN Quan. Research Progress on Vesicular Stomatitis Virus-based Oncolytic Virotherapy[J]. China Biotechnology, 2020, 40(6): 53-62.
[12] TONG Mei,CHENG Yong-qing,LIU Jin-yi,XU Chen. Construction of a Strain for Promoting Production of Small Molecule Antibodies in Periplasmic Space of Escherichia coli[J]. China Biotechnology, 2020, 40(5): 48-56.
[13] DAI Qi-nan,ZHANG Jing-hong. Advances in Molecular Mechanisms Related to Tumor Multi-drug Resistance, Autophagy, DNA Repair and Tumor Stem Cells[J]. China Biotechnology, 2020, 40(4): 69-77.
[14] QIAN Ying,QIAN Chen,BAI Xiao-qing,WANG Jing-jing. Application of Adjuvant in Cancer Immunotherapy[J]. China Biotechnology, 2020, 40(3): 96-103.
[15] MAO Hui,LV Yu-hua,ZHU Li-hui,LIN Yue-xia,LIAO Rong-rong. The Role of Exosomes in the Diagnosis and Treatment of Viral Infection[J]. China Biotechnology, 2020, 40(3): 104-110.